![A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//18075932/0000006700000005/v1_202212011555/S1807593222018178/v1_202212011555/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfuNpdT3pEXC7tmqfbE1Y0Z1p9+vAlVDCDNpqpxHzzp8Z0ILrOhT7YePrkmPFgJXhRefw4ABU3JKFsav571eCDEBUhjI79Bed2vwyg+06u15e5p0zEc7NR8pKOODemQ8Jl7shbpnR5Z7fS6msjciMc9exfReX6xEt3CpsUcLrQq2+COvxzN0YvO0v9diCVzdtXH5DjBo0uguSf7DejoHnqvOJgN9DgkVeQr5ZRPIsThWOr2uAw3C2JxlJ7ad8KbJ5A=)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics
![PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/49394150/mini_magick20190131-26445-njjm3w.png?1548982026)
PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu
![High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka](https://cyberleninka.org/viewer_images/1232370/f/1.png)
High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka
![Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors](https://static.hindawi.com/articles/dm/volume-2019/3890906/figures/3890906.fig.001.jpg)
Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors
![Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma](https://www.mdpi.com/sensors/sensors-21-03567/article_deploy/html/images/sensors-21-03567-g001.png)
Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma
![A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article](https://cyberleninka.org/viewer_images/1481894/f/1.png)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article
![Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0039914020302824-fx1.jpg)
Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect
![Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma](https://pub.mdpi-res.com/sensors/sensors-21-03567/article_deploy/html/images/sensors-21-03567-ag.png?1626330784)
Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia | British Journal of Cancer HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2016.247/MediaObjects/41416_2016_Article_BFbjc2016247_Fig1_HTML.jpg)
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia | British Journal of Cancer
![Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825811009735-fx2.jpg)
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
![HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | SpringerLink HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13277-011-0204-3/MediaObjects/13277_2011_204_Fig1_HTML.gif)
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | SpringerLink
![Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ad5e941b87910036df87050d122d3db985bbadce/3-TableIII-1.png)
Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
![Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/21/10/006.jpg)
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2487ea26-1e5f-4b40-9ecd-fddbb803589d/ntbl003.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-13-00452/article_deploy/html/images/diagnostics-13-00452-g001.png?1675751411)
Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
![Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer](https://www.frontiersin.org/files/Articles/364491/fonc-08-00124-HTML/image_m/fonc-08-00124-g001.jpg)
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
![Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation | SpringerLink Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-022-03387-4/MediaObjects/428_2022_3387_Fig1_HTML.jpg)
Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation | SpringerLink
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1746-1596-8-11/MediaObjects/13000_2012_Article_730_Fig1_HTML.jpg)